METHODOLOGICAL STUDIES

Václav Hampl



Archer S. L., Hampl V.:
NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise.
Biochemical and Biophysical Research Communications 188: 590-596, 1992
(Click here for abstract)

Arginine analogs, such as NG-monomethyl-L-arginine (L-NMMA) or NG-nitro-L-arginine (L-NA), are commonly used as inhibitors of the synthesis of endothelium-derived relaxing factor, nitric oxide (NO). However, their effect on NO levels is rarely measured. Using a chemiluminescence assay for NO, we found that L-NMMA (but not L-NA) enhanced, rather than reduced, NO synthesis in pulmonary arterial and aortic rings. Thus L-NMMA is a partial agonist for NO synthesis.



Archer S. L., Hampl V., Nelson D., Sidney E., Peterson D. A., Weir E. K.:
Dithionite increases radical formation and decreases vasoconstriction in the lung: evidence that dithionite does not mimic alveolar hypoxia.
Circulation Research 77: 174-181; 1995.
(Click here for abstract)

Many studies of hypoxic pulmonary vasoconstriction use oxygen scavenger, dithionite, rather than authentic hypoxia. In this study we demonstrated that using dithionite for this purpose is incorrect, because dithionite causes only very transient decrease of PO2 in isolated ventilated perfused lungs and elicits a massive burst of radical formation (Figure). This is in sharp contrast to ventilatory hypoxia, which actually reduces radical synthesis in this preparation (Figure).

Unlike ventilatory hypoxia (left), dithionite (right) causes a massive outburst of radical production and only a transient decrease in PO2 in isolated perfused rat lungs.

Isolated rat lungs were perfused with Krabs-albumin solution at constant flow rate (0.04 ml/min/g body weight), so that increases in pulmonary arterial (PA) pressure reflect vasoconstriction. Radicals production was measured as luminol-enhanced chemiluminescence.



Dillon W. C., Hampl V., Shultz P. J., Rubins J. B., Archer S. L.:
Origins of breath nitric oxide in humans.
Chest 110: 930-938; 1996.
(Click here for abstract)

After nitric oxide (NO), an important endogenously produced vasodilator, was found in human breath, it was hoped for some time that its measurement could be used for diagnostics of pulmonary vascular disease. We therefore decided to find out what is the main source of NO in the human breath. Using the chemiluminescence assay of NO, we found the main source of NO in the human breath to be the nose, while the contribution from the distal airways is negligible (Figure).

Concentration of nitric oxide (NO) in exhaled air collected in the nose is much higher that in air sampled in the mouth, trachea, carina and distal airway(n=7).

Samples from the trachea are from 9 intubated patients, while all the other values are from 7 patients before (nose, mouth) and during (carina, distal airway) bronchoscopic examination. The data are the means±SEM.
*P<0.001 vs. all other locations.



Hampl V., Archer S. L., Russell J. C., Nelson D. P., Weir E. K.:
Lack of endothelial dysfunction in the young genetically hyperlipidemic JCR:LA-cp rats
Journal of Vascular Medicine and Biology 4: 187-196; 1993

In this study we found that, in contrast to other models of hypercholesterolemia, endothelium-dependent vasodilation is not impaired in a genetically hyperlipidemic (JCR:LA-cp) strain of rats.